glp-1 drugs risks Medications Infographic Long-Term Effects Of GLP-1 Medications:

Researchers and leading pharma scientists now ask: could GLP-1s be our first true longevity drugs

95% CI 1.112.78), clinicians have remained cautious

Use of the diabetes medication Ozempic and other GLP-1 drugs for weight loss is rising

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

other outcomes were cardiovascular and total death, nonfatal myocardial infarction (MI), nonfatal stroke, hospitalization for heart failure (HHF), and renal outcome